Evidence map›Paper›PMID 19223617›Full record

ArticleAntimicrobial agents and chemotherapy2009

Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.

M Mar Rodríguez, Enrique Calvo, Carolina Serena, Marçal Mariné, F Javier Pastor, Josep Guarro

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. SystemicInfection and drug resistance · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Experimental therapy with azoles against Candida guilliermondii.Antimicrobial agents and chemotherapy · 2014
    Article
  9. Review
  10. Emerging fungal infections in solid organ transplant recipients.Infectious disease clinics of North America · 2013
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Melanized fungi in human disease.Clinical microbiology reviews · 2010
    Review
  17. Article
  18. Article
  19. Successful Treatment ofAllergy & rhinology (Providence, R.I.)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M Mar RodríguezUnitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
Enrique Calvo
Carolina Serena
Marçal Mariné
F Javier Pastor
Josep Guarro
Institut d'Investigació Sanitària Pere Virgili · ESUniversidad Rovira i Virgili · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have evaluated the efficacies of micafungin, amphotericin B, and voriconazole, alone and in double and triple combinations, in a murine model of systemic infection by Scedosporium prolificans. Micafungin combined with voriconazole or amphotericin B was the most effective, these being the only treatments able to prolong survival and to reduce the fungal load in the kidneys and brain. Triple combinations of these drugs did not improve the results obtained with double combinations.

Indexed as

Amphotericin BAntifungal AgentsEchinocandinsLipopeptidesPyrimidinesTriazolesAnimalsBrainDisease Models, AnimalDrug Resistance, FungalDrug Therapy, CombinationHumansKidneyMaleMicafunginMiceAmphotericin BAntifungal AgentsEchinocandinsLipopeptidesMicafunginPyrimidinesTriazolesVoriconazole

Identifiers

PMID19223617
PMCPMC2681574
OpenAlexW2145599980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.